Furthermore, the siRNA/pIL-12 codelivery system exhibited good potential in preventing HBV-induced hepatocellular carcinoma by suppressing the PI3K/Akt and ERK pathways. The gene discussed is AKT1; the disease is hepatocellular carcinoma.